Sign in

CIK 0001781174

  • Emerging growth company

Acrivon Therapeutics, Inc.

Sign in to watch
Ticker
ACRV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
825125532
Phone
+1 617-207-8979
Business address
480 ARSENAL WAY, SUITE 100, WATERTOWN, MA, 02472
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$37,028
in 8 filings

Net −$37,028. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-17 Peterson Katharine Chief Accounting Officer Sale −107 $1.45 $155 17,926
2026-11-17 Miller Mary Chief Legal Officer Sale −193 $1.45 $280 81,009
2026-11-17 Gamelin Erick Chief Development Officer Sale −416 $1.45 $603 52,176
2026-11-17 Devroe Eric Chief Operating Officer Sale −628 $1.45 $911 145,721
2026-11-17 Blume-Jensen Peter President and CEO Sale −1,276 $1.45 $2K 2,228,776
2026-11-17 Blume-Jensen Peter President and CEO Sale −504 $1.45 $731 385,355
2026-10-22 Miller Mary Chief Legal Officer Sale −513 $1.84 $944 81,202
2026-10-05 Miller Mary Chief Legal Officer Sale −294 $1.99 $585 81,715
2026-08-31 Levin Michaela Chief Business Officer Grant or award +30,000 30,000
2026-08-31 Levin Michaela Chief Business Officer Grant or award · Stock Option (Right to Buy) +130,000 130,000
2026-08-25 Blume-Jensen Peter President and CEO Sale −14,036 $2.21 $31K 2,230,052
2026-08-18 Peterson Katharine Chief Accounting Officer Sale −101 $2.01 $203 18,033
2026-08-18 Miller Mary Chief Legal Officer Sale −185 $2.01 $372 82,009
2026-08-18 Gamelin Erick Chief Development Officer Sale −400 $2.01 $804 52,592
2026-08-18 Devroe Eric Chief Operating Officer Sale −604 $2.01 $1K 146,349
2026-08-18 Blume-Jensen Peter President and CEO Sale −1,229 $2.01 $2K 2,244,088
2026-08-18 Blume-Jensen Peter President and CEO Sale −484 $2.01 $973 385,859
2026-08-04 Levy Adam D. Chief Financial Officer Sale −1,142 $1.57 $2K 66,008
2026-07-21 Miller Mary Chief Legal Officer Sale −573 $1.76 $1K 82,194
2026-06-17 RA CAPITAL MANAGEMENT, L.P. Director Grant or award · Stock Option (Right to Buy) +20,275 20,275

Page 1 of 12 · 235 trades